Coronavirus Breaking News

The coronavirus disease COVID-19 is currently reaching pandemic levels in various countries.

Sep 20, 2020 • 9:04 pm CDT

Canada’s Public Safety Minister Bill Blair tweeted on September 18, 2020, "We are extending non-essential travel restrictions with the USA until October 21st, 2020. And the Canada Border Services Agency is reminding all travelers who are celebrating the Rosh Hashanah (September 18 to 20, 2020) and Yom Kippur (September 27 and 28, 2020) holidays, those travel restrictions remain n place at all Canadian international border crossings including land, marine, air and rail ports of entry.

If you are driving to the United States, you can now consult Canada to U.S. border online wait times.

Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement on September 20, 2020: 'Labs across Canada tested an average of 47,111 people daily over the past week with 1.4% testing positive of COVID-19. I urge all Canadians to take action now to slow the spread of the coronavirus.'

Sep 20, 2020 • 11:35 am CDT

The Washington University School of Medicine announced on September 3, 2020, it is the clinical coordinating center for an ambitious, international clinical trial, which is the first to evaluate on a large scale whether the common MMR vaccine can protect against COVID-19.

Data from the trial sites will be compiled at University College London. Laurence Lovat, M.D., Ph.D., a professor of gastroenterology and biophotonics, is the study leader in the United Kingdom. “If we discover that the MMR vaccine can help train the body’s immune response to SARS-CoV-2 infection, then we will have something to administer very quickly while waiting for more specific vaccines and preventive therapies to be developed,”

Medical Review by
Sep 20, 2020 • 5:46 am CDT

'Almost 33% of COVID-19 fatalities recorded by the UK's Office for National Statistics in July and August 2020 were 'primarily caused by other conditions, not related to SARS-CoV-2 virus' reported Oxford University researchers. The Telegraph reported on September 18, 2020, the Oxford researcher found 'someone who had a heart attack may have been included in figures if they had also tested positive for the coronavirus.'

The study found COVID-19 was not the main cause of death in 465 cases out of 1,617 people.

The latest Oxford study came as it emerged that COVID-19 is no longer in the top ten of England’s causes of death. Dr. Jason Oke, with the Centre of Evidence-Based Medicine at Oxford, added: 'people had been dying “with” the disease rather than “from” it," reported the DailyMail.

Sep 19, 2020 • 2:20 pm CDT

The developers of the Russian Sputnik V vaccine have defended the clinical trial data they presented during August 2020, in a new letter published in The Lancet on September 18, 2020. The letter to the Lancet's editorial board, 'emphasized that all the data presented were obtained in ‘experiments and double-checked,’ reported the TASS news agency.

Furthermore, deputy director Denis Logunov and the letter co-authors at the Gamaleya Center based in Russia promised to 'provide access to certain volunteers, so that all the existing issues are clarified.'

Medical Review by
Sep 19, 2020 • 5:55 am CDT

According to Reuters reporting on September 18, 2020, R-Pharm’s Coronavir treatment for outpatients with mild to moderate COVID-19 infections will be sold in pharmacies in Russia. R-Pharm stated it received approval for Coronavir after the completion of Phase III clinical trials involving 168 patients diagnosed with COVID-19.

Coronavir was first approved for in-hospital use to treat Russian patients with COVID-19 in July 2020, according to a government registry.

Coronavir is sold under various names around the world, including Avigan, FabiFlu, Avifavir, Ciplenza, FluGuard, Avifavir, and is an active form, favipiravir-RTP (favipiravir ribofuranosyl-5′-triphosphate).

Medical Review by
Sep 18, 2020 • 7:07 pm CDT

According to France's Public Health Agency, 13,215 people have tested positive for COVID-19 on September 18, 2020, making it the highest largest number of infections recorded in a single day since the coronavirus outbreak of 2020 began, reported XinhuaNet.

In France, the cumulative number of confirmed COVID-19 cases now totals 428,696.

Sep 18, 2020 • 2:26 pm CDT

On September 18, 2020, the U.S. CDC issued a new statement: 'Due to the significance of asymptomatic and pre-symptomatic transmission, this guidance further reinforces the need to test asymptomatic persons, including close contacts of a person with documented SARS-CoV-2 infection.'

The CDC recommendations for SARS-CoV-2 testing have been developed based on what is currently known about COVID-19 and are subject to change as additional information becomes available.

And, the U.S. FDA has not authorized using antibody tests to diagnose SARS-CoV-2 infection, and the CDC does not currently recommend using antibody testing as the sole basis for diagnosis of acute infection. In certain situations, serologic assays may be used to support a clinical assessment of persons who present late in their illnesses when used in conjunction with viral detection tests.

Sep 18, 2020 • 1:45 pm CDT

Although the risks for SARS-CoV-2 transmission have been extensively investigated, the in-flight transmission of the virus has not been formally confirmed, stated a team of researchers.

According to an Early Release study published by the U.S. CDC on September 18, 2020, four persons with SARS-CoV-2 infection recently traveled on the same flight from Boston, Massachusetts to Hong Kong, China. Given the case histories and sequencing results, the most likely sequence of events is that one or both of passengers A and B contracted SARS-CoV-2 in North America and transmitted the virus to flight attendants C and D during the flight.

The airplane was the only location where all 4 persons were in close proximity for an extended period.

Furthermore, their virus genetic sequences were found to be identical, unique, and belong to a clade not previously identified in Hong Kong, which strongly suggests that the virus can be transmitted during air travel.

Sep 18, 2020 • 1:25 pm CDT

Nationally, based on death certificate data as of September 18, 2020, the percentage of fatalities attributed to pneumonia, influenza, or COVID-19 (PIC) for week #37 was found to be 6.2%. This data is currently lower than the percentage reported during week #36 (9.3%).

However, this percentage could increase as more PIC related death certificates are processed says the U.S. CDC.

Sep 18, 2020 • 12:33 pm CDT

France based Sanofi and GSK announced they have finalized an advanced purchase agreement with the European Commission for the supply of up to 300 million doses of a COVID-19 vaccine, once the vaccine is approved. This final agreement confirms the announcement made on July 31, 2020, and marks a key milestone in protecting European populations against COVID-19.

Previously, the companies announced the launch of a Phase 1/2 clinical study on September 3rd. And stated a 'Phase 3 study is planned to begin by the end of 2020 and regulatory approval could be requested in the first half of 2021.'

Sep 18, 2020 • 7:58 am CDT

A student at South Middle School in Arlington Heights, Chicago, showed the world how digital innovations can be used to help reduce the coronavirus pandemic of 2020. Twelve-year-old Vince Radlicz morphed his 3D printer into a plastic face shield-maker in March, spurred by the needs of a nurse at Mount Sinai Hospital in Chicago when the COVID-19 pandemic hit.

As coronavirus cases continued to increase, Radlicz didn’t rest until hundreds of his creations had been delivered to hospitals, nursing homes, and other healthcare facilities across Chicago and its suburbs free of charge.

“Some of them went as far as California. It kind of snowballed after we first started doing it,” said Vince. He added that it felt amazing to help people just by doing something he loves, reported Marisa Sloan at Northwestern University of September 16, 2020.

Sep 18, 2020 • 6:09 am CDT

The government's systems to find people who might pass on coronavirus infections to others, known as contact tracing, are in disarray across Europe and the USA, reported the WSJ on September 17, 2020. In France, Spain, and England investigators have been interviewing far fewer contacts of infected people than officials expected.

With many governments unwilling to reimpose sweeping lockdowns, epidemiologists say swift contact tracing is essential to limit the spread of the SARS-CoV-2 virus because infected people become contagious before they develop symptoms. That means the contacts of people who have tested positive must be identified and isolated quickly before they unknowingly infect others.

One positive case-study is the Republic of Singapore, which has enhanced its national-level contact tracing efforts by requiring anyone entering a public venue to be scanned for a QR code or identity cards to verify health status.

This effort contrasts with some U.S. states and big cities, where investigators aren’t contacting many people who test positive, and those who are reached, often don’t disclose their contacts. That has prevented investigators from casting a wide net to stop new infections. The full WSJ article is found at this link.

Sep 17, 2020 • 10:54 pm CDT

As of September 17, 2020, the U.S. FDA has authorized 248 coronavirus diagnostic tests, which include 198 molecular tests, 46 antibody tests, and 4 antigen tests. And, there have been 100,269,291 tests reported in the USA.

Sep 17, 2020 • 6:50 pm CDT

France's Health Minister Olivier Véran announced on September 17, 2020, 'extra measures will soon be implemented to curb the spreading of COVID-19 in the cities of Lyon and Nice. These cities will join Marseille, Bordeaux, and Guadeloupe, a French territory in the Caribbean, as coronavirus “red zones” where additional measures are already in place, reported France24.

According to data services, France registered 10,593 new confirmed coronavirus cases on September 17th, setting a new daily record. During 2020, France has confirmed 31,095 fatalities related to COVID-19.

Sep 17, 2020 • 2:55 pm CDT

Texas Governor Greg Abbott held a press conference on September 17, 2020, updating the public on the state's ongoing efforts to combat COVID-19. During the press conference, the Governor issued Executive Orders expanding occupancy levels for restaurants, retail stores, office buildings, manufacturing facilities, gyms and exercise facilities and classes, museums, and libraries, and re-authorizing elective surgeries for a majority of the state of Texas.

The Governor also announced new guidance related to visitations at nursing homes and long-term care facilities across the state.

"With the medical advancements we have made and the personal hygiene practices we have adopted, Texans have shown that we can address both the health and safety concerns of COVID-19 while also taking careful, measured steps to restore the livelihoods that Texans depend on," said Governor Abbott.

Medical Review by